(Q34209373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

liquid chromatography-tandem mass spectrometry

14 February 2020

main subject

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Lie Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ming Zhao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Fariba Navid

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Keith Pratz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

B Doug Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Michelle A Rudek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

9 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

3033-3038

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

14 February 2020

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Sorafenib: a review of its use in advanced hepatocellular carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Potential role of sorafenib in the treatment of acute myeloid leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Development of a rapid and sensitive LC-MS/MS assay for the determination of sorafenib in human plasma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

Factors affecting cytochrome P-450 3A activity in cancer patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956857

A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20870468

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JCHROMB.2010.08.049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20870468%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

20870468

1 reference